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Of 1300 epileptic patients 76 (5.8%) were found to have juvenile myoclonic epilepsy (JME). These 76 patients were examined 
at the epilepsy outpatient clinic of Bakirkoy State Hospital for Neurological and Psychiatric Diseases between 1991 and 1996 
and data obtained were analysed retrospectively. Clinically typical absence seizures were reported in 40.8%, myoclonic jerks 
in lOO%, and generalized tonic<lonic seizures in 82.9% of the patients. Neurological and mental examination was normal 
for all patients with the exception of three cases; two with essential tremor and one with minimal dysarthria. Precipitating 
factors were noted in 85.5% of cases. Abnormal EEG was recorded in 73 (6.1%) patients. Abnormalities mainly consisted of 
generalized discharges of spike/polyspike and slow-wave (86.6%) and generalized paroxysmal theta or delta (9.2%). Fifteen 
(19.7%) had focal abnormalities and 20 (26.4%) had photoconvulsive discharges. Of the 76 patients, 40 (52.6%) were not 
diagnosed at the initial interview; definite diagnosis was delayed by a mean of 5.9 years. As a result of misdiagnosis at 
the initial interview 40 patients had been administered AED except for valproate. After reassessment of clinical and EEG 
findings, the medication was changed to valproate therapy. As a result, 65 of our JME patients (85.5%) were seizure free 
after a one-year follow-up period. 
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INTRODUCTION 
Juvenile myoclonic epilepsy (JME) is a generalized 
idiopathic epileptic syndrome with age-related on- 
set and a prevalence of 5-l 1% amongst other forms 
of epilepsy. The following features distinguish the 
disease from other seizure disorders; (1) typical ab- 
sence seizures (AS), myoclonic jerks (MJ), and gen- 
eralized tonic-clonic seizures (GTCS) in a consistent 
age-related sequence; (2) circadian distribution and 
characteristic seizure-precipitating factors; (3) normal 
physical examination and CT brain scan; (4) charac- 
teristic EEG with generalized 4-6 Hz spike/multiple 
spike and slow waves; (5) family history of epilepsy; 
(6) complete remission of seizures in 80% of patients 
treated with appropriate anticonvulsants”‘. 
Despite these certain diagnostic criteria, JME is still 
misdiagnosed by physicians and even experienced 
neurologists . 1-4 We investigated our cases retrospec- 
tively to assess the pitfalls in JME diagnosis. 
METHODS AND PATIENTS 
Data from 76 (27 female, 49 male) patients with 
JME examined at the epilepsy outpatient clinic of 
Bakirkiiy State Hospital for Neurological and Psychi- 
atric Diseases between 1991 and 1996 were analysed 
retrospectively. All patients had well-documented di- 
agnoses of JME, based on both clinical and EEG 
findings (according to previously published diagnos- 
tic criteria by Panayiotopoulos et al 1989)5. Patients 
were evaluated according to the following features; 
(a) demographic and clinical data (prevalence, type 
of seizures and age at onset, precipitating factors, 
family history of epilepsy, neurological and mental 
examination, initial diagnosis, age at correct diagno- 
sis, duration, and causes of delay in diagnosis), (b) 
EEG findings, (c) neuroimaging findings, (d) initial 
treatment, (e) response to treatment. 
EEG examinations were performed using a 16- 
channel Medelec 1118 device. We obtained conven- 
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tional EEG recordings from all patients along with 
activating methods. The patients with normal EEG 
findings were invited for a second EEG evaluation 
after 24-hour sleep deprivation (n = 28). The AED 
therapy that patients had already been taking was con- 
tinued. 
RESULTS 
Of 1300 patients with epilepsy 76 (5.8%) were found 
to have JME. All 76 patients were found to have my- 
oclonic jerks (MJ). Thirty one (40.8%) also had typ- 
ical absence seizures (AS) and 63 (82.9%) had gen- 
eralized tonic-clonic seizures (GTCS). Five (6.6%) 
of our patients only had MJ, 40 had GTCS and 
MJ (52.6%), eight had AS and MJ (lOS%), and 23 
had MJ, AS and GTCS (30.3%). The age of onset 
ranged from 11 to 23 years (mean: 12.5 f2.12 years) 
with AS, MJ and GTCS beginning at a mean age of 
12.53f4.49 (3-23), 15.09f2.47 (9-23), 15.42f3.17 
(8-23) years, respectively. 
Precipitating factors were detected in 65 (85.5%) 
patients. These were, in order of frequency, sleep 
deprivation (85.5%), photic stimulation (25%), stress 
(18.4%), fatigue (11.8%), and menstruation (2.6%). 
A reliable family history of epilepsy was obtained 
in 33 (43.4%) patients. First- or second-degree rela- 
tives with JME were noted in seven (9.2%) patients. 
These members were a parent, an uncle, two siblings, 
two cousins and a nephew. Three of them expand 
mild absences whereas four of them were diagnosed 
on both clinical and EEG grounds, three only on a 
clinical basis. Consanguinity was noted in 22 (28.9%) 
patients’ parents. Only two of seven relatives diag- 
nosed as JME were amongst families with consan- 
guinity marriages. 
Neurological and mental examination was normal 
in all patients, except for two essential tremor and 
one minimal dysarthria cases. Except for three EEG 
recordings showing an excess of theta activity, back- 
ground activity was normal in all patients. 
All of the CT (n = 33) and MRI (n = 3) investi- 
gations of the patients were normal. Of the 76 pa- 
tients, 40 (52.6%) were misdiagnosed at the ini- 
tial evaluation. The most common misdiagnosis was 
GTCS (n = 28), followed by complex partial seizures 
(n = 11) and simple partial seizures (n = 1). Mean 
age at the correct diagnosis was 22.5 f3.5 years (12- 
38 years). Definite diagnosis was delayed by a mean 
of 5.9 years (from 6 months to 14 years). 
All of the misdiagnosed cases were previously 
evaluated by neurologists or physicians in different 
centres. The factors responsible for the delayed diag- 
nosis were multiple. Of the 40 misdiagnosed patients, 
28 were not questioned about myoclonic jerks. In 18 
Table 1: Features of EEG in JME. 
n % 
Normal 3 
Abnormal 73 
With generalized spike/polyspike 
and slow waves 66 86.8 
Generalized paroxysmal theta or 
delta I 0.2 
Photosensitivity 20 26.4 
Apparent asymmetry in magnitude 
of generalized discharges 38 50 
Focal abnormalities 15 19.7 
Table 2: AED therapy in misdiaanosed !xouP. 
n -% 
Carbamazepine 19 25 
Phenytoin 6 7.9 
Phenobarbital 2 2.6 
Carbamazepine + phenytoin 1 1.3 
Carbamazepine + phenobarbital 7 9.2 
Phenvtoin+phenobarbital 5 6.6 
Table 3: Current AED therapy. 
n % 
Valproate 
Valproate + phenytoin 
Valproate + phenobarbital 
Valproate + clonazepam 
Valproate + ethosuccimide 
Phenobarbital + clonazepam 
Carbamazepine + clonazepam 
Clonazepam 
68 89 
1 1.3 
1 1.3 
1 1.3 
1 1.3 
1 1.3 
2 2.6 
1 1.3 
Table 4: Response to therapy according to the seizure types. 
% 
Complete Control 6ng 85.5 
Complete control in GTCS, and MJ, 
partial control in absences* 4 5.3 
Complete control in GTCS and AS 
partial control in MJ 3 3.9 
Complete control in MJ and AS, 
partial control in GTCS 2 2.6 
Partial control in MJ and GTCS 2 2.6 
*Partial seizure control: reduction over 50%. 
of 28 patients EEG was not appreciated despite typ- 
ical generalized spike/polyspike and slow-wave ab- 
normalities. Twelve patients with focal EEG abnor- 
malities were misdiagnosed as having complex partial 
seizures (n = 11) and simple partial seizures (n = 1) 
with secondary generalization. 
As a result of misdiagnosis at the initial evaluation, 
40 patients had been administered various AEDs ex- 
cept for VPA. It was found that CBZ and PHT exac- 
erbated myoclonic jerks in 16 and four patients, re- 
spectively. Moreover, CBZ induced absences in four 
patients and polytherapy with CBZ, PHT and PB ag- 
gravated the frequency of myoclonic jerks in eight 
patients. 
After reassessment of clinical and EEG findings, 
the medication of the misdiagnosed group were 
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changed to VPA therapy (Table 3) and 65 patients 
(85.5%-including 35 of misdiagnosed group) were 
seizure free after a follow-up period ranging from 1 
to 11 years. The remaining 11 patients showed a re- 
markable improvement (Table 4). We did not try to 
discontinue the therapy even after a long seizure-free 
period. 
DISCUSSION 
We have demonstrated that JME is a common epilep- 
tic syndrome in our country (5.8%). It is similar to 
the prevalence of JME (5-l 1%) reported in various 
studies’*“,c9. 
In addition to MJ, more than 80% of JME pa- 
tients presented with GTCS after awakening6,7, ‘n. 
The other seizure type which may be associated with 
JME is absence, accounting for approximately IO- 
40% of cases’,6q7. In our study GTCS was found in 
82.9% and AS in 40.8% of our patients. 
Mean age at onset of MJ and GTCS in our study 
is consistent with the previous reports. On the other 
hand, mean age at onset of AS was found to be 
slightly higher in our group”3.6.7,9-‘3. 
The most common seizure-precipitating factors in 
this study were sleep deprivation, photic stimulation, 
stress, fatigue and menstruation. Alcohol was not 
found to be an important precipitating factor probably 
because of its limited consumption in our country. 
Genetic factors are clearly of aetiological impor- 
tance. We found a high family history of epilepsy 
(43.4%) and consanguinity (28.8%) as reported in 
previous studies. It is similar to the rates reported 
by Penryt” (36%), Grtinewald’ (33.3%) Clement” 
(50%) and Panayiotopoulos4 (48.7%, Saudi Arabia). 
Consanguinity in our patients’ families was lower 
than Panayiotopoulos’ study4 (43.9%, Saudi Arabia). 
Despite well-defined clinical and EEG features, JME 
remains underestimated by physicians’. Misdiagnosis 
of JME has been emphasized by Janz7, Asconapel’ 
(8.5 years), Grtlnewald’ (14.5 years), Panayiotopou- 
10s~ (8.3 years). Comparisons of delay in diagnosis 
between these studies and our’s (5.9 years) show that 
the diagnostic yield improved with heightened med- 
ical awareness. The factors responsible for the de- 
layed diagnosis of JME in our study were often mul- 
tiple. In many cases the seizure history was inade- 
quate, such as patients not being questioned about 
MJ. Most of the patients did not complain of my- 
oclonic jerks and these were revealed only by ques- 
tioning. In some cases physicians seemed to be un- 
aware of the syndrome. Another factor in misdiagno- 
sis may be presence of atypical EEG findings. The 
characteristic finding is a paroxysmal, generalized, 
symmetric polyspike and slow-wave discharge. Fo- 
cal abnormalities were found in 15 (19.7%), and ap- 
parent asymmetry in magnitude of generalized dis- 
charges in 38 (50%) patients. Our focal abnormality 
rate was lower than Panayiotopoulos” (30.3%), Alib- 
ertis (54.5%) and Grtinewald’ (33%) studies. Clinical 
and EEG asymmetries in JME patients are frequent 
causes of misdiagnosis’ ’ . LancmanJ4 noted asymme- 
tries in 30.6% of his patients; 16.5% had clinical 
and 16.5% EEG asymmetries. But, he evaluated uni- 
lateral polyspike and slow-wave discharges together 
with asymmetries in voltage and found EEG asym- 
metries in 16.5% of his patients. 
The typical and patognomonic epileptic discharges 
were found in 86.6% of cases. Twenty patients 
(26.4%) had photosensitivity. These results are simi- 
lar to previous reports],“. 
Treatment with VPA is effective for JME. Although 
AED therapy with phenytoin, pirimidone, phenobar- 
bital or even carbamazepine would control some of 
the seizure components of JME, it may also cause ag- 
gravation of seizures or even addition of new seizure 
types. In our study, as a result of misdiagnosis at 
the initial assessment. 40 patients had been admin- 
istered various AEDs except for VPA. In the mis- 
diagnosed group, CBZ exacerbated MJ in 16 pa- 
tients and phenytoin in four patients, while polyther- 
apy with CBZ-PHT or CBZ-PB aggravated the fre- 
quency of MJ in eight patients. Moreover. CBZ in- 
duced AS in four patients. Valproate is the only avail- 
able AED has been shown to be effective in control- 
ling the seizure components of JME without signif- 
icant side effects. The significance of the correct di- 
agnosis was reflected in response to treatment. Sixty- 
five patients (85.5%) were seizure free for at least 
1 year, while 11 (14.4%) patients showed remarkable 
improvement and of those patients 68 (89%) were 
receiving valproate monotherapy. These results are 
similar to Penry’s study’“. 
In conclusion, despite the high rate of consan- 
guineous marriages. the prevalence of JME is lower 
in our study, which may be related to ongoing mis- 
diagnosis. On the other hand, the relatively shorter 
time we needed to establish the correct diagnosis in- 
dicates that having knowledge and experience in this 
area as well as obtaining adequate history from the 
patient would increase the rate of correct diagnosis 
and prevalence in the near future. 
REFERENCES 
I. Griinewald, R.A.. Chomi, E. and Panayiotopoulos, C.P. De- 
layed diagnosis of juvenile myoclonic epilepsy. Journal of 
Neurology, Neurosurgen’ and Psychicmy 1992; 55: 497499. 
2. Panayiotopoulos, C.P., Tahan, R. and Obeid, T. Juvenile my- 
oclonic epilepsy: Factors of error involved in the diagnosis 
and treatment. Epilepsin 199 1; 32(5): 672-676. 
66 Dilek Atakli et a/ 
3. Panayiotopoulos, C.P., Obeid, T. and Tahan, R. Juvenile my- 
oclonic epilepsy: A 5 year prospective study. Epilepsia 1994; 
35(2): 285-296. 
4. Panayiotopoulos, C.P. Juvenile myoclonic epilepsy: an un- 
derdiagnosed syndrome. In: Epileptic Seizures and Syndromes 
(Ed. Peter Wolf). 1994, London: John Libbey, pp. 221-230. 
5. Panayiotopoulos, C.P., Obeid, T. and Waheed, G. Absences 
in juvenile myoclonic epilepsy. A clinical and video-EEG 
study. Annals of Neurology 1989; 25: 391-397. 
6. Obeid, T. and Panayiotopoulos, C.P. Juvenile myoclonic 
epilepsy: A study in Saudi Arabia. Epilepsia 1988; 29(3): 
280-282. 
7. Janz, D. Epilepsy with impulsive petit ma1 (juvenile my- 
oclonic epilepsy). Acta Neuroiogica Scandinavica 1985; 72: 
449-459. 
8. Aliberti, V., Griinewald, R.A., Panayiotopoulos, C.P. and 
Chroni, E. Focal electroencephalographic abnormalities in ju- 
venile myoclonic epilepsy. Epilepsiu 1994; 3.5(2): 297-301. 
9. Griinewald, R.A. and Panayiotopoulos, C.P. Juvenile my- 
oclonic epilepsy, a review. Archives of Neurology 1993; 50: 
594-598. 
10. Asconape, J. and Penry, K. Some clinical and EEG aspects of 
beningn juvenile myoclonic epilepsy. Epilepsia 1984; 25( 1): 
108-l 14. 
Il. Clement, M.J. and Wallace, S.J. Juvenile myoclonic epilepsy. 
Archives of Disease in Childhood 1988; 63: 1049-1053. 
12. Shian Wen-Jye and Chi Ching-Shiang, Juvenile myoclonic 
epilepsy. Chinese Medical Journal (Taipei) 1994; 53: 375- 
378. 
13. Pem-y, J.K., Dean, J.C. and Riela, A.R. Juvenile myoclonic 
epilepsy: Long term response to therapy. Epilepsia 1989; 30 
(Suppl. 4): s19-~23. 
14. Lancman, M.E., Asconape, J.J. and Penry, J.K. Clinical and 
EEG asymmetries in juvenile myoclonic epilepsy. Epilepsia 
1994; 35(2): 302-306. 
